{
  "id": 6622927,
  "title": "AAP issues recommendations for pediatric RSV vaccination in 2026-2027 season",
  "url": "https://urgent.news/2026/09/10/aap-issues-recommendations-for-pediatric-rsv-vaccination-in-2026-2027",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-09-10T19:00:06.000Z",
  "source": {
    "name": "Medical Xpress",
    "slug": "medical-xpress",
    "url": "https://medicalxpress.com/news/2026-09-aap-issues-pediatric-rsv-vaccination.html"
  },
  "original_language": "en",
  "account": null,
  "summary": "The American Academy of Pediatrics (AAP) has issued updated recommendations for pediatric RSV vaccination in the 2026-2027 season, expanding the categories of high-risk children eligible for the vaccine. The AAP Committee on Infectious Diseases recommends RSV immunization for all infants younger than 8 months born during or entering their first RSV season, unless they have documented protection from prenatal vaccination. Additionally, RSV vaccination is recommended for children ages 8 through 19 months at high risk for severe RSV disease who are entering their second RSV season. These high-risk children include those born preterm, with congenital heart disease, pulmonary abnormalities, neuromuscular disorders, and chromosomal differences. The AAP also recommends the 2026-2027 COVID-19 vaccine for all infants and children ages 6 through 23 months, as well as a single dose for children ages 2 through 18 with increased risk for severe COVID-19, regardless of prior vaccination status.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}